2011 ACCF/AHA Focused Update of the Guideline for the Management of Patients With Peripheral Artery Disease (Updating the 2005 Guideline)
Authors:
- Thom W. RookeTRThom W. Rooke
- Alan T. HirschAHAlan T. Hirsch
- Sanjay MisraSMSanjay Misra
- Anton N. SidawyASAnton N. Sidawy
- Joshua A. BeckmanJBJoshua A. Beckman
- Laura K. FindeissLFLaura K. Findeiss
- Jafar GolzarianJGJafar Golzarian
- Heather L. GornikHGHeather L. Gornik
- Jonathan L. HalperinJHJonathan L. Halperin
- Michael R. JaffMJMichael R. Jaff
- Gregory L. MonetaGMGregory L. Moneta
- Jeffrey W. OlinJOJeffrey W. Olin
Top Cited Papers
- 1 November 2011
- Vol. 58 (19) , 2020-2045
Abstract
No abstract availableKeywords
Funding Information
- American College of Cardiology Foundation
- American Historical Association
This publication has 66 references indexed in Scilit:
- Revascularization versus Medical Therapy for Renal-Artery StenosisNew England Journal of Medicine, 2009
- Ankle Brachial Index Combined With Framingham Risk Score to Predict Cardiovascular Events and MortalityJAMA, 2008
- Effect on Cessation Counseling of Documenting Smoking Status as a Routine Vital Sign: An ACORN StudyThe Annals of Family Medicine, 2008
- Patients With Prior Myocardial Infarction, Stroke, or Symptomatic Peripheral Arterial Disease in the CHARISMA TrialJACC, 2007
- Stent revascularization for the prevention of cardiovascular and renal events among patients with renal artery stenosis and systolic hypertension: Rationale and design of the CORAL trialAmerican Heart Journal, 2006
- Two-Year Outcomes after Conventional or Endovascular Repair of Abdominal Aortic AneurysmsNew England Journal of Medicine, 2005
- Revascularisation of renal artery stenosis caused by fibromuscular dysplasia: effects on blood pressure during 7-year follow-up are influenced by duration of hypertension and branch artery stenosisJournal of Human Hypertension, 2005
- Clopidogrel added to aspirin versus aspirin alone in secondary prevention and high-risk primary prevention: Rationale and design of the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trialAmerican Heart Journal, 2004
- Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patientsBMJ, 2002
- A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)The Lancet, 1996